Back to Trials
NCT07246993NARecruiting

Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms

University of Minnesota

Start Date

3/5/2026

Completion Date

1/1/2028

Summary

This project investigates an innovative combination of non-invasive neuromodulation (transcranial direct current stimulation - tDCS) and cognitive training as a novel treatment approach aimed at improving function in individuals suffering from persistent post-concussive syndrome (PPCS) following mild traumatic brain injury (mTBI).

Eligibility Criteria

Age Range: 18 years to 65 years

Inclusion Criteria: * Age 18-65 * Has sustained a single mTBI 3-12 months prior to enrollment * Meets criteria for PPCS (assessed using the CP Screen) * Has reliable access to a smartphone Exclusion Criteria: * Inability to provide informed consent or complete study procedures * History of moderate/severe TBI * Significant neurological or psychiatric disorders (other than PPCS-related symptoms like mild depression/anxiety) * Substance dependence within the last six months * Contraindications to tDCS (e.g., implanted metal, skin lesions on scalp)

Interventions

DEVICE

Active tDCS

DEVICE

Sham tDCS

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Persistent Post Concussion SyndromeMild Traumatic Brain Injury

Locations

University of Minnesota

Minneapolis, Minnesota 55455

United States